<DOC>
	<DOCNO>NCT01316445</DOCNO>
	<brief_summary>Approximately 3 million individual suffer epilepsy America alone 200,000 new case epilepsy America diagnose year ( Epilepsy Foundation , 2005 ) . Epilepsy define condition person recurrent , unprovoked seizure . Prolonged back-to-back repetitive seizure , know `` acute repetitive seizure '' ( ARS ) , medical emergency . ARS occur unexpectedly , circumstance quick efficient antiepileptic drug need household prehospital use . Currently , benzodiazepine antiepileptic drug choice deal ARS proven efficient take little time work . Benzodiazepines administer mouth , vein via needle ( intravenously ; IV ) , rectally , cheek gum ( buccally ) , nose ( intranasally ; IN ) . The nasal formulation yet FDA-approved . The rectal treatment route commonly use acute seizure treatment past year , recent study propose nasal route benzodiazepine may better overall home treatment easy administer ( see Wermeling , 2009 ) . For many `` hospital '' situation , nasal benzodiazepine convenient comfortable rectal treatment . In addition benefit , nasal benzodiazepine rapidly absorb blood vessel nose time drug administration cessation seizure may thus reduce use nasal route . This study set characterize fast buccal nasal treatment begin work brain monitoring brain wave administration drug , determine whether nasal buccal administration best .</brief_summary>
	<brief_title>Pharmacodynamics Nasal Buccal Midazolam Using EEG</brief_title>
	<detailed_description>Past out-of-hospital treatment acute epileptic seizure meet limited effectiveness , convenience , speed , safety . The FDA-approved treatment acute repetitive seizure must give rectally , nasal buccal midazolam show least effective . The purpose study characterize time effect brain activity intranasal ( nasal ) midazolam compare buccal midazolam . This research recruit patient epilepsy undergoing EEG recording clinical purpose , include intracranial EEG . EEG evaluate administration buccal nasal midazolam augmentation beta wave signify action midazolam brain , time effect compare buccal nasal formulation . Subjects give brief survey administration evaluate sedation , discomfort adverse effect medication . This study help characterize action nasal buccal benzodiazepine determine effective method administration .</detailed_description>
	<mesh_term>Midazolam</mesh_term>
	<criteria>adult undergo extracranial EEG Epilepsy Monitoring Unit adult undergo intracranial EEG Epilepsy Monitoring Unit adult chronically implant intracranial neurostimulators capacity continuous intracranial EEG monitoring patient additional sedative medication ( narcotic , central nervous system depressant ) patient document sensitivity adverse reaction benzodiazepine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Electroencephalography</keyword>
	<keyword>Benzodiazepines</keyword>
	<keyword>Midazolam</keyword>
</DOC>